Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Journal of Clinical Medicine|October 26, 2024
Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CTManojkumar Bupathi, Benjamin Garmezy, Michael Lattanzi, et al.Tomography (Ann Arbor, Mich.)|April 30, 2021
Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.Physics in Medicine and Biology|August 11, 2023
Performance of an automated registration-based method for longitudinal lesion matching and comparison to inter-reader variabilityDaniel T Huff, Victor Santoro-Fernandes, Song Chen, et al.Radiology. Imaging Cancer|May 2, 2025
Evaluating Automated Tools for Lesion Detection on 18F Fluoroestradiol PET/CT Images and Assessment of Concordance with Standard-of-Care Imaging in Metastatic Breast CancerRenee Miller, Mark Battle, Kristen Wangerin, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2024
Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcomeOjaswita Lokre, Timothy G Perk, Amy J Weisman, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2025
Full-Body Tumor Response Heterogeneity of Metastatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radiopharmaceutical TherapyVictor Santoro-Fernandes, Brayden Schott, Amy J Weisman, et al.Physics in Medicine and Biology|July 14, 2021
Development and validation of a longitudinal soft-tissue metastatic lesion matching algorithmVictor Santoro-Fernandes, Daniel Huff, Mathew L Scarpelli, et al.Clinical Genitourinary Cancer|August 3, 2024
Assessing the Heterogeneity of Response of [68Ga] Ga-PSMA-11 PET/CT Lesions in Patients With Biochemical Recurrence of Prostate CancerMikaela Dell'Oro, Daniel T Huff, Ojaswita Lokre, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2019
Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate CancerDouglas G McNeel, Jens C Eickhoff, Laura E Johnson, et al.Clinical Genitourinary Cancer|June 22, 2019
Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate CancerAlison R Roth, Stephanie A Harmon, Timothy G Perk, et al.Pageof 3